Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...

Small and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...

NSE shares have slipped below their IPO price after a brief listing-day rally, wiping out nearly Rs 41,000 crore from the exchange’s peak m...

The government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...

The GST Council is set to meet regarding the regulation of industrial alcohol, which has been contested between the government and states. ...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

India is set to implement significant reforms to the goods and services tax system, which will ease compliance. Changes may include the rel...

Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens E...

Dr Lal PathLabs Ltd has recently experienced a rally but could not maintain its peak price levels. Experts suggest that the stock may targe...

India’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...

In an exciting development, Rasayan Labs has unveiled a groundbreaking AI-based platform to enhance computational chemistry and drug discov...

Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...

The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...

Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...

HRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...

Drugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...